Sonmol
PrivateLast Round
Strategic
Jul 18, 2024
Est. Valuation
$367.08M
Total Funding Raised
$173.68M
Company Overview
Sonmol is a digital health company that develops AI-powered respiratory disease management platforms and connected medical devices for the diagnosis and treatment of conditions such as asthma and COPD.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Telemedicine, Patient Engagement
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sonmol Comparables
Compare Sonmol with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ResMed Inc | 83% | |
| Cohero Health, Inc. | 78% | |
| Adherium Limited | 77% |
Sonmol Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 18, 2024 | ||||
| Series E Extension | Aug 19, 2022 | ||||
| Series E | Nov 1, 2021 | ||||
| Series D | Dec 22, 2020 | ||||
| Series C | Aug 1, 2019 | ||||
Series B Extension | Oct 22, 2018 |
Sonmol Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series E |
| ZhenFund | Series B, Angel |
| 健壹资本 | Series C |
| Shanghai Shengyu Equity Investment Fund Management | Series E |
| CRCM Ventures | Angel |
| Sunshine Insurance Group | Series D |
| CICC ALPHA | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2024
$8.3M raised from Changchun City Equity Investment Fund Management Co., Ltd.
- Aug 19, 2022
Completed a Series E Extension round of funding.
Sonmol Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sonmol's valuation, stock price, and market status.
Is Sonmol a public or private company?
Sonmol is a private company.
What is the current stock price of Sonmol?
Sonmol is a private company with no public stock price. Caplight tracks Sonmol's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Sonmol worth (valuation)?
Sonmol's valuation is estimated at $367.1M based on funding round data.
Can I buy Sonmol stock?
Sonmol shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sonmol's last funding round?
Sonmol's most recent funding round was Strategic on July 18, 2024.
Who are the main investors in Sonmol?
Key investors in Sonmol include IDG Capital, ZhenFund, HongShan, CICC ALPHA, Xiang He Capital.
Will Sonmol IPO soon?
No public IPO plans have been announced for Sonmol.
How can I track Sonmol secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sonmol's secondary market activity and sign up for updates.